<DOC>
	<DOCNO>NCT02737020</DOCNO>
	<brief_summary>This study evaluate use Rhodiola rosea treatment Attention Deficit/Hyperactivity Disorder ( ADHD ) adult . Half participant receive Rhodiola rosea , half receive placebo .</brief_summary>
	<brief_title>Rhodiola Rosea Adults With Attention Deficit/Hyperactivity Disorder</brief_title>
	<detailed_description>Rhodiola rosea herbal medicine use century various medical condition . Many randomize controlled trial evaluate usefulness stress fatigue . There benefit attention study . Mild side effect beneficial antioxidant property make reasonable assessment potential benefit adult ADHD . To knowledge , Rhodiola rosea never study ADHD .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<criteria>Fulfillment Diagnostic Statistical Manual Mental Disorders , Fifth Edition , ( DSM5 ) diagnostic criterion ADHD Adults Intelligence Quotient ( IQ ) 70 Eligibility Rhodiola rosea clinical contraindication fro Rhodiola rosea unstable chronic illness without proper treatment ( hypertension , heart , kidney liver disease ) significant neurological disease ( delirium , dementia , epilepsy , AIDS , head trauma , multiple sclerosis , stroke , etc ) unstable psychiatric comorbidities require immediate treatment ( risk suicide , current Substance Use Disorder , etc . ) pregnant , nurse absence reliable contraception current use nicotine ( &lt; 30 day ) use anticoagulant current use psychoactive drug ( &lt; 30 day ) prior use stimulant current lifetime psychosis current lifetime bipolar disorder</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>ADHD</keyword>
	<keyword>Adults</keyword>
	<keyword>Treatment</keyword>
	<keyword>Rhodiola rosea</keyword>
</DOC>